rs373187237
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_004260.4(RECQL4):c.2503G>A(p.Asp835Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000878 in 1,571,176 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RECQL4 | ENST00000617875.6 | c.2503G>A | p.Asp835Asn | missense_variant | 15/21 | 1 | NM_004260.4 | ENSP00000482313.2 | ||
RECQL4 | ENST00000621189.4 | c.1432G>A | p.Asp478Asn | missense_variant | 14/20 | 1 | ENSP00000483145.1 | |||
RECQL4 | ENST00000534626.6 | c.673G>A | p.Asp225Asn | missense_variant | 6/8 | 5 | ENSP00000477457.1 | |||
ENSG00000265393 | ENST00000580385.1 | n.271+262C>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000133 AC: 20AN: 150530Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000130 AC: 27AN: 207494Hom.: 1 AF XY: 0.000160 AC XY: 18AN XY: 112408
GnomAD4 exome AF: 0.0000831 AC: 118AN: 1420646Hom.: 1 Cov.: 66 AF XY: 0.0000984 AC XY: 69AN XY: 701416
GnomAD4 genome AF: 0.000133 AC: 20AN: 150530Hom.: 0 Cov.: 34 AF XY: 0.000177 AC XY: 13AN XY: 73438
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 22, 2025 | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Rothmund-Thomson syndrome type 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | St. Jude Molecular Pathology, St. Jude Children's Research Hospital | Oct 16, 2023 | The RECQL4 c.2503G>A (p.Asp835Asn) missense change has a maximum subpopulation frequency of 0.046% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). In silico tools are inconclusive about a pathogenic or benign effect of this variant on protein function, and to our knowledge functional studies have not been performed. To our knowledge, this variant has not been reported in individuals with RECQL4-associated conditions. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. - |
Baller-Gerold syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at